Navigation Links
Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
Date:3/31/2008

Results of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) involving 25,620 patients presented today at the 57th Annual Scientific Session of the American College of Cardiology

and published online in the New England Journal of Medicine

CHICAGO, March 31 /PRNewswire/ -- The results of the landmark ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), a second-generation angiotensin II receptor blocker (ARB), is equally effective as the current standard, ramipril, in reducing the risk of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure in a broad cross-section of high-risk cardiovascular patients with normal blood pressure or controlled high blood pressure, and resulted in fewer discontinuations.(1) These cardiovascular events occurred in 1,423 patients (16.7 percent) receiving telmisartan versus 1,412 patients (16.5 percent) receiving ramipril.(1) The relative risk (ratio of the probability of the event occurring in the telmisartan group versus the ramipril group) was 1.01, with a 95 percent CI of 0.94 - 1.09.

Telmisartan is now the only ARB to have demonstrated cardio and vascular risk reduction benefits beyond lowering blood pressure in this high-risk population;(1) these benefits may be attributed to the specific pharmacological properties and mode of action of the drug. Previously, in 2000, the HOPE trial showed that the cardiovascular risk for patients treated with the angiotensin-converting enzyme (ACE) inhibitor ramipril was reduced by approximately 20 percent compared with placebo.(2) This meant that every fifth serious cardiovascular event in a high risk group of patients was prevented.(2)

"The ONTARGET trial shows that telmisartan is a well-tolerated treatment in high-risk cardiovascular patients that is as effective as ramipril in preventing heart attacks, stroke and hospitalizations for heart failure and dea
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Viatronix V3D-Colon Utilized in Another Landmark Study
3. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
4. Hospital Launches Landmark Emergency Medicine Project
5. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
6. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MONICA, Calif. , Aug. 28, 2014  In anticipation ... new infographic is being made available for the first time. ... San Diego offers a snapshot of ... industry. Highlighting everything from the latest employment statistics ... has made San Diego such a ...
(Date:8/28/2014)... Levi & Korsinsky announces that a class ... District Court for the District of Nevada ... Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... Period the Company violated federal securities laws by issuing ...
(Date:8/28/2014)... N.C. , Aug. 28, 2014   ... marketplace, today announced a worldwide search for product ... the senior population.  Promising ideas uncovered through the ... to leading medical device manufacturers and healthcare retailers ... improve the lives of individuals age 65 and ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... PARIS--(BUSINESS WIRE)--Jun 11, 2007 - Regulatory News-Ipsen,(Paris:IPN) announced ... III study for its investigational 4-month formulation,of triptorelin ... triptorelin for a duration of 4 months in ... the second,administration as planned in the protocol. No ...
... 11, 2007 /PRNewswire/ -- NovaCardia, Inc.,today presented preliminary ... an adenosine A1 receptor antagonist in development for ... (CHF),that indicate a strong trend toward efficacy for ... a higher rate of,improvement in dyspnea, or shortness ...
Cached Medicine Technology:Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 2Phase III Clinical Trial with 4-Month Long-Acting Formulation of,Triptorelin: Ipsen Decides Not to Perform Further Administration 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4
(Date:8/29/2014)... (PRWEB) August 29, 2014 The Florida ... the Hyatt Regency Orlando last week August 21-24 and ... returned as a presenter. , Dr. Greenstein ... the 21st Century was a standing room session; (2) ... – Doctors of Chiropractic Leading the Way in Injury ...
(Date:8/29/2014)... August 29, 2014 Canadian Healthy ... Canada, recently completed its annual survey of its 200 ... emerged of the products that appeal to Canadian consumer ... asked to list their top five selling healthy snacks ... is an increasingly important issue for consumers, employers, and ...
(Date:8/29/2014)... 2014 The Department of Health ... (FDA), Center for Food Safety and Applied Nutrition ... quantity (IDIQ) contract and the first two task ... Modernization and Enhancement (DME) for FARM VI” to ... Overarching contract objectives include:, ,     Upgrade ...
(Date:8/29/2014)... 2014 Under Section 946.300, Qualifications for ... “The physician shall not…advertise in a cultivation center or ... What the state of Illinois has done is create ... potential patients entering their care. The goal is to ... pharmacies and with typical prescription medications. Medical steering is ...
(Date:8/28/2014)... August 29, 2014 Career Step, an ... released a new video designed to help students and ... coding and billing field. The video details what medical ... for these professionals, and the education requirements for entering ... option that’s often overlooked when people are considering a ...
Breaking Medicine News(10 mins):Health News:Sport and Spine Rehab’s CEO Presents at the Florida Chiropractic Association National Convention and Expo 2014 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 2Health News:Survey Results: What Products Do Canadians Want in Their Healthy Vending Machines? 3Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 3Health News:Medical Marijuana Company Provides Solution for Illinois Marketing Regulations 2Health News:Career Step Releases New Video Designed to Help Students Explore the Medical Coding and Billing Field 2
... ... Consumer Confidence That Will Come With These Long Awaited Manufacturing Regulations, , ... (PRWEB) June ... heralds the Food and Drug Administration,s (FDA) final step in enforcing its current ...
... ... targets an audience of teens and young adults in an effort to empower parents to ... , ... -- Kids Into Safe Skin (K.I.S.S) announced today the official launch of its not-for-profit organization, ...
... men can recall familiar faces faster and more accurately ... both sides of their brains, according to a new ... in the journal, Laterality: Asymmetries of Body, Brain ... orientation and whether we,re right-or-left-handed on our ability to ...
... UK,s National Physical Laboratory (NPL) is involved in a collaborative ... viral protein structure which could lead to new molecular medicines. ... from NPL, the University of Edinburgh and IBM T.J. Watson ... of Physical Chemistry B . The article sets out ...
... More ... ... EBSCO Publishing (EBSCO) began providing key database content free of charge in 2008 ... routines. Two free EBSCOhost® resources, GreenFILE™ , and Library, Information Science & ...
... cesareans due to ,failed inductions, researchers find , TUESDAY, ... doubles the risk of having a cesarean delivery, according ... to a link that experts have long suspected. , ... study author Dr. Deborah Ehrenthal, director of women,s health ...
Cached Medicine News:Health News:Small Supplement And Vitamin Manufacturers Must Meet FDA cGMP Requirements By The End Of The Month 2Health News:Small Supplement And Vitamin Manufacturers Must Meet FDA cGMP Requirements By The End Of The Month 3Health News:Small Supplement And Vitamin Manufacturers Must Meet FDA cGMP Requirements By The End Of The Month 4Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 2Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 3Health News:Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention 4Health News:Gay men's bilateral brains better at remembering faces: York U study 2Health News:Viral protein structure study offers HIV therapy hope 2Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 2Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 3Health News:Free Resources from EBSCO Publishing Providing Useful Information to Researchers 4Health News:Labor Induction May Boost C-Section Risk 2Health News:Labor Induction May Boost C-Section Risk 3
... Vitrasert implant is a device ... with Aids-related Cytomegalovirus (CMV) Retinitis. This ... CMV when compared with conventional intravenous ... embedded in a polymer-based system that ...
Includes near contrast sensitivity card, calibrated holder, light meter, answer key and instruction manual contrast vision test developed by Arthur P. Ginsburg, Ph.D....
Near PT test card/illus of the ocular adnexa 5 1/2" X 8"....
Near PT test card/shorthand /PH stock market 5 1/2 " X 8"...
Medicine Products: